Skip Navigation


JAC Advance Access originally published online on November 29, 2008
Journal of Antimicrobial Chemotherapy 2009 63(2):302-308; doi:10.1093/jac/dkn485
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
63/2/302    most recent
dkn485v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Randall, L. P.
Right arrow Articles by Clifton-Hadley, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Randall, L. P.
Right arrow Articles by Clifton-Hadley, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Veterinary Laboratories Agency. © Crown Copyright 2008. Reproduced with the permission of the Controller of Her Majesty's Stationery Office

Original research

Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains

L. P. Randall1,*, M. Kirchner1, C. J. Teale1, N. G. Coldham1, E. Liebana2 and F. Clifton-Hadley1

1 Veterinary Laboratories Agency (Weybridge), New Haw, Addlestone, Surrey KT15 3NB, UK 2 European Food Safety Authority (EFSA), Biological Hazards Unit, Largo N. Palli 5/A, I-43100 Parma, Italy

Received 26 September 2008; returned 15 October 2008; revised 28 October 2008; accepted 30 October 2008

* Corresponding author. Tel: +44-1932-357582; Fax: +44-1932-347046; E-mail: l.randall{at}vla.defra.gsi.gov.uk

Objectives: The aim of this study was to evaluate CHROMagar CTX (CHROMagar France), a novel agar for the selective isolation of Enterobacteriaceae expressing the blaCTX-M gene in the presence of enteric bacteria expressing AmpC enzymes.

Methods: A panel of 150 Gram-negative bacteria (mainly Escherichia coli, Enterobacter, Klebsiella, Pseudomonas and Salmonella) isolated from humans and animals were assembled for the purpose of evaluating CHROMagar CTX and comparing it with CHROMagar ECC with the addition of 1, 2, 4 and 8 mg/L cefotaxime or ceftazidime and with bioMérieux extended-spectrum β-lactamase (ESBL)-Bx agar. CHROMagar CTX was also assessed for its ability to isolate blaCTX-M strains from farm animal faeces (n = 342).

Results: The panel contained CTX-M-positive (n = 70) strains (CTX-M types 1, 9, 14 and 15), ESBLs (n = 31) belonging to other families (OXA, PER, SHV, TEM, VEB), strains positive for ampC genes (n = 31), strains that overexpressed ampC (n = 6), non-ESBL/AmpC strains (n = 11) and Klebsiella oxytoca (n = 1). CHROMagar CTX was superior to other agars tested for selective isolation of Enterobacteriaceae expressing the blaCTX-M gene with 100% sensitivity and 64.2% specificity for CTX-M strains in the panel and 90.1% of the colonies from animal faeces plated on CHROMagar CTX were CTX-M strains.

Conclusions: CHROMagar CTX is a valuable agar in situations where it is important to isolate blaCTX-M strains in the presence of AmpC strains. The agar may be particularly useful in veterinary studies, where AmpC-producing commensal E. coli can be encountered reasonably frequently in the enteric flora of some animal species and may also be useful, following further evaluation, for samples from humans.

Keywords: blaCTX-M , Escherichia spp. , selective , chromogenic , agar


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.